Attitude toward PG:
The mean (±SD) total attitude score was 21.18 (±2.58) out of 24. The
vast majority of respondents had a positive attitude on all surveyed
attitude items. For instance, approximately 77% of respondents agreed
that PG testing will help to improve drug efficacy, 72% believed that
it will help to decrease the time it takes to find the optimal dose of a
drug, and almost 77% agreed that it will enable them to effectively
control drug therapy expenditures. Encouragingly, 64.2% of our sample
expressed interest in attending training sessions or workshops on PG in
the future.
Moreover, there were no significant differences in mean total attitude
score based on gender (p=0.13), age groups (p= 0.19), or primary work
settings (p= 0.35). However, stratifying respondents according to
seniority levels showed a significant difference in mean total attitude
score, as the specialist physicians were found to have a higher mean
attitude score (21.69 ± 2.54) compared to residents (20.57 ± 2.65;p=0.03 ), as detailed in Table 2.